The world's scientific and social network for malaria professionals
Subscribe to free Newsletter | 11110 malaria professionals are enjoying the free benefits of MalariaWorld today

HIV-1

Open Access | Marked increase in etravirine and saquinavir plasma concentrations during atovaquone/proguanil prophylaxis

May 25, 2011 - 08:57 -- Kabogo Ndegwa
Author(s): 
Tommasi C, Bellagamba R, Tempestilli M, D'Avolio A, Gallo AL, Ivanovic J, Nicastri E, Pucillo LP, Narciso P
Reference: 
Malaria Journal 2011, 10:141 (21 May 2011)

The case of a 32-year-old Caucasian female with multi-drug resistant HIV-1 subtype B infection treated with a salvage regimen including maraviroc, raltegravir, etravirine and unboosted saquinavir who started atovaquone/proguanil prophylaxis, is reported.

Medical Condition: 

Open Access | Sequence similarity between the erythrocyte binding domain 1 of the Plasmodium vivax Duffy Binding Protein and the V3 loop of HIV-1 strain MN reveals binding residues for the Duffy Antigen Receptor for Chemokines

February 4, 2011 - 08:03 -- Patrick Sampao
Author(s): 
Bolton MJ, Garry RF
Reference: 
Virology Journal 2011, 8:45 (31 January 2011)

Variable loop 3 (V3) of HIV-1 SU and subdomain 1 of the Plasmodium vivax DBP share a sequence similarity. The site of amino acid sequence similarity was necessary, but not sufficient, for DARC binding and contained a consensus heparin binding site essential for DARC binding. Both HIV-1 and P. vivax can be blocked from binding to their chemokine receptors by the chemokine, RANTES and its analog AOP-RANTES.

Medical Condition: 
Medical Treatment: 

Viewpoint: African Burkitt's lymphoma: could collaboration with HIV-1 and malaria programmes reduce the high mortality rate?

May 10, 2010 - 12:54 -- Patrick Sampao
Author(s): 
Sam M Mbulaiteye, Ambrose O Talisuna, Martin D Ogwang, F Ellis McKenzie, John L Ziegler, Donald M Parkin
Reference: 
The Lancet, Volume 375, Issue 9726, 8 May 2010-14 May 2010, Pages 1661-1663

No abstract available

Continent: 
Natural Disaster: 

Malaria hemozoin modulates susceptibility of immature monocyte-derived dendritic cells to HIV-1 infection by inducing a mature-like phenotype

March 15, 2010 - 11:18 -- Ingeborg van Schayk
Author(s): 
Juliette Diou, Mélanie R. Tardif, Corinne Barat and Michel J. Tremblay
Reference: 
Cellular Microbiology, Early View

There is still limited information about the putative impact of the malaria pigment hemozoin (HZ) on the dissemination of HIV-1. As so, we propose a premise where HZ present in human dendritic cells (DCs) could modulate HIV-1 transfer to CD4+ T cells. 

Subscribe to RSS - HIV-1